Dr Reddys launches Raloxifene hydrochloride tablets in US
Hyderabad : Dr Reddys Laboratories has launched raloxifene hydrochloride tablets in 60 mg, a therapeutic equivalent generic version of Evista tablets, in the United States market.
The tablets were launched following the approval by the US Food and Drug Administration (USFDA).
Dr Reddys Raloxifene tablets are available in 60 mg in bottle count sizes of 30, 100 and 1,000, a press release from the city-based drug maker said.
Evista brand and generic had USA sales of approximately USD 265 million for the most recent 12 months ending September 2016, according to IMS Health.
Evista is a registered trademark of Eli Lilly and Company.